244 related articles for article (PubMed ID: 12099201)
1. Sulfasalazine therapy for juvenile rheumatoid arthritis.
Chen CC; Lin YT; Yang YH; Chiang BL
J Formos Med Assoc; 2002 Feb; 101(2):110-6. PubMed ID: 12099201
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of azathioprine therapy for juvenile rheumatoid arthritis.
Lin YT; Yang YH; Tsai MJ; Chiang BL
J Formos Med Assoc; 2000 Apr; 99(4):330-5. PubMed ID: 10870318
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis.
Lin YT; Tsai MJ; Wang LH; Huang MT; Yang YH; Chiang BL
J Formos Med Assoc; 2000 Aug; 99(8):623-9. PubMed ID: 10969505
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment.
van Rossum MA; van Soesbergen RM; Boers M; Zwinderman AH; Fiselier TJ; Franssen MJ; ten Cate R; van Suijlekom-Smit LW; Wulffraat NM; van Luijk WH; Oostveen JC; Kuis W; Dijkmans BA;
Ann Rheum Dis; 2007 Nov; 66(11):1518-24. PubMed ID: 17491099
[TBL] [Abstract][Full Text] [Related]
5. Sulphasalazine in the treatment of children with chronic arthritis.
Huang JL; Chen LC
Clin Rheumatol; 1998; 17(5):359-63. PubMed ID: 9805178
[TBL] [Abstract][Full Text] [Related]
6. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group.
van Rossum MA; Fiselier TJ; Franssen MJ; Zwinderman AH; ten Cate R; van Suijlekom-Smit LW; van Luijk WH; van Soesbergen RM; Wulffraat NM; Oostveen JC; Kuis W; Dijkstra PF; van Ede CF; Dijkmans BA
Arthritis Rheum; 1998 May; 41(5):808-16. PubMed ID: 9588731
[TBL] [Abstract][Full Text] [Related]
7. Sulfasalazine therapy for juvenile rheumatoid arthritis.
Imundo LF; Jacobs JC
J Rheumatol; 1996 Feb; 23(2):360-6. PubMed ID: 8882047
[TBL] [Abstract][Full Text] [Related]
8. High toxicity of sulfasalazine in adult-onset Still's disease.
Jung JH; Jun JB; Yoo DH; Kim TH; Jung SS; Lee IH; Bae SC; Kim SY
Clin Exp Rheumatol; 2000; 18(2):245-8. PubMed ID: 10812499
[TBL] [Abstract][Full Text] [Related]
9. Sulfasalazine for the management of juvenile rheumatoid arthritis.
Brooks CD
J Rheumatol; 2001 Apr; 28(4):845-53. PubMed ID: 11327261
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
[TBL] [Abstract][Full Text] [Related]
11. Effects of sulfasalazine treatment on serum immunoglobulin levels in children with juvenile chronic arthritis.
van Rossum MA; Fiselier TJ; Franssen MJ; ten Cate R; van Suijlekom-Smit LW; Wulffraat NM; van Luijk WH; Oostveen JC; Kuis W; Dijkmans BA; van Soesbergen RM;
Scand J Rheumatol; 2001; 30(1):25-30. PubMed ID: 11252688
[TBL] [Abstract][Full Text] [Related]
12. A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
Hissink Muller PC; Brinkman DM; Schonenberg D; Koopman-Keemink Y; Brederije IC; Bekkering WP; Kuijpers TW; van Rossum MA; van Suijlekom-Smit LW; van den Berg JM; Allaart CF; Ten Cate R
Pediatr Rheumatol Online J; 2017 Feb; 15(1):11. PubMed ID: 28166785
[TBL] [Abstract][Full Text] [Related]
13. Treatment continuation rate in relation to efficacy and toxicity in long-term therapy with low-dose methotrexate, sulfasalazine, and bucillamine in 1,358 Japanese patients with rheumatoid arthritis.
Nagashima M; Matsuoka T; Saitoh K; Koyama T; Kikuchi O; Yoshino S
Clin Exp Rheumatol; 2006; 24(3):260-7. PubMed ID: 16870092
[TBL] [Abstract][Full Text] [Related]
14. Current treatment of juvenile rheumatoid arthritis.
Ilowite NT
Pediatrics; 2002 Jan; 109(1):109-15. PubMed ID: 11773549
[TBL] [Abstract][Full Text] [Related]
15. Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.
Cummins L; Katikireddi VS; Shankaranarayana S; Su KY; Duggan E; Videm V; Pahau H; Thomas R
Intern Med J; 2015 Dec; 45(12):1266-73. PubMed ID: 26384029
[TBL] [Abstract][Full Text] [Related]
16. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
17. [Methotrexate treatment in refractory juvenile rheumatoid arthritis].
Brik R
Harefuah; 1998 Dec; 135(11):509-11, 567. PubMed ID: 10911466
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients naive to both drugs.
Schipper LG; Fransen J; Barrera P; Van Riel PL
Rheumatology (Oxford); 2009 Jul; 48(7):828-33. PubMed ID: 19458163
[TBL] [Abstract][Full Text] [Related]
19. Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis.
Varbanova BB; Dyankov ED
Adv Exp Med Biol; 1999; 455():331-6. PubMed ID: 10599365
[TBL] [Abstract][Full Text] [Related]
20. A follow-up study of systemic-onset juvenile rheumatoid arthritis in children.
Lin SJ; Huang JL; Chao HC; Lee WY; Yang MH
Acta Paediatr Taiwan; 1999; 40(3):176-81. PubMed ID: 10910610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
